Best Bypass Surgery (BBS) Trial
Off-Pump Coronary Artery Bypass Grafting Versus Conventional Coronary Artery Bypass Grafting on Postoperative Mortality and Morbidity, A Randomized Clinical Trial
1 other identifier
interventional
341
1 country
1
Brief Summary
There is evidence linking cardiopulmonary bypass to negative side effects when used for coronary artery bypass grafting. Coronary artery bypass grafting can be performed without the use of cardiopulmonary bypass. The purpose of this study is to determine the positive and negative effects of coronary artery bypass grafting with or without the use of cardiopulmonary bypass. The patients will be followed at least one year after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Apr 2002
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2002
CompletedFirst Submitted
Initial submission to the registry
July 8, 2005
CompletedFirst Posted
Study publicly available on registry
July 19, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedMarch 3, 2008
February 1, 2008
3.9 years
July 8, 2005
February 29, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
All cause mortality
Short and long term
Acute myocardial infarction
Cardiac arrest with successful resuscitation
Low cardiac output syndrome/cardiogenic shock
Stroke
Need for renewed cardiac revascularization procedure
Secondary Outcomes (12)
Hyper dynamic shock
Atrial fibrillation during index admission
Need for pacing > 24 hours
Renal complications, i.e., increased serum creatinine
Reoperation for bleeding during index admission
- +7 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Known ischemic three vessel heart disease affecting one of the marginal coronary arteries
- Age \> 54 years
- Scheduled for elective or subacute CABG
- EuroSCORE \> 4 and \< 17
- The patient has signed written informed consent before randomization and surgery.
You may not qualify if:
- Previous heart surgery
- Ejection fraction \< 30 %
- Unstable preoperative condition, i.e., continuous infusion of inotropics on the day of the operation
- Patient unable to give informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rigshospitalet, Denmarklead
- Danish Heart Foundationcollaborator
- The Danish Medical Research Councilcollaborator
- Copenhagen Hospital Corporationcollaborator
Study Sites (1)
Dept. Cardiothoracic Surgery, Rigshospitalet
Copenhagen, 2100, Denmark
Related Publications (3)
Moller CH, Perko MJ, Lund JT, Andersen LW, Kelbaek H, Madsen JK, Winkel P, Gluud C, Steinbruchel DA. Three-year follow-up in a subset of high-risk patients randomly assigned to off-pump versus on-pump coronary artery bypass surgery: the Best Bypass Surgery trial. Heart. 2011 Jun;97(11):907-13. doi: 10.1136/hrt.2010.211680. Epub 2011 Mar 17.
PMID: 21415073DERIVEDMoller CH, Perko MJ, Lund JT, Andersen LW, Kelbaek H, Madsen JK, Winkel P, Gluud C, Steinbruchel DA. No major differences in 30-day outcomes in high-risk patients randomized to off-pump versus on-pump coronary bypass surgery: the best bypass surgery trial. Circulation. 2010 Feb 2;121(4):498-504. doi: 10.1161/CIRCULATIONAHA.109.880443. Epub 2010 Jan 18.
PMID: 20083683DERIVEDJensen BO, Rasmussen LS, Steinbruchel DA. Cognitive outcomes in elderly high-risk patients 1 year after off-pump versus on-pump coronary artery bypass grafting. A randomized trial. Eur J Cardiothorac Surg. 2008 Nov;34(5):1016-21. doi: 10.1016/j.ejcts.2008.07.053. Epub 2008 Sep 7.
PMID: 18778948DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian H. Møller, MD
Dept. of Cardiothoracic Surgery and Copenhagen Trial Unit, Rigshospitalet, Copenhagen
- STUDY DIRECTOR
Daniel A. Steinbrüchel, Professor
Dept. of Cardiothoracic Surgery, Rigshospitalet, Copenhagen
- STUDY CHAIR
Christian Gluud, Consultant
Copenhagen Trial Unit, Rigshospitalet, Copenhagen
- STUDY CHAIR
Jan K. Madsen, Consultant
Dept. of Cardiology, Amtssygehuset i Gentofte, Copenhagen
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 8, 2005
First Posted
July 19, 2005
Study Start
April 1, 2002
Primary Completion
March 1, 2006
Study Completion
July 1, 2008
Last Updated
March 3, 2008
Record last verified: 2008-02